Clinical Trial

Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocognitive Disorders in Patients With Unruptured Arteriovenous Malformations Before and After Surgical Treatment

Study acronym: APEMMAV-NR
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of the clinical trial is to describe perfusion and metabolic alterations in different brain regions before and six months after surgical treatment of arteriovenous malformations in adult patients with unruptured arteriovenous malformations.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-07-08
notable Primary completion pushed: 2028-11 -> 2028-12 2026-07-08
minor Completion pushed: 2028-11 -> 2028-12 2026-07-08
Trial Details
NCT Number NCT07569887
Lead Sponsor University Hospital, Montpellier
Conditions Unruptured Brain Arteriovenous Malformation
Enrollment 10 participants
Start Date 2026-06-16
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-07